These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9284196)
1. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer. Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196 [TBL] [Abstract][Full Text] [Related]
2. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237 [TBL] [Abstract][Full Text] [Related]
3. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer. Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845 [TBL] [Abstract][Full Text] [Related]
4. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy. Arenas LF; Füllhase C; Boemans P; Fichtner J Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944 [TBL] [Abstract][Full Text] [Related]
5. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940 [TBL] [Abstract][Full Text] [Related]
6. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI. Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669 [TBL] [Abstract][Full Text] [Related]
7. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577 [TBL] [Abstract][Full Text] [Related]
8. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
9. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. Rogers E; Gürpinar T; Dillioglugil O; Kattan MW; Goad JR; Scardino PT; Griffith DP Br J Urol; 1996 Sep; 78(3):419-25. PubMed ID: 8881954 [TBL] [Abstract][Full Text] [Related]
10. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy. Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337 [TBL] [Abstract][Full Text] [Related]
11. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120 [TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer. Fournier GR; Narayan P Br J Urol; 1993 Oct; 72(4):484-8. PubMed ID: 7505192 [TBL] [Abstract][Full Text] [Related]
13. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT. Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685 [TBL] [Abstract][Full Text] [Related]
14. Predicting pelvic lymph node involvement in current-era prostate cancer. Rahman S; Cosmatos H; Dave G; Williams S; Tome M Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478 [TBL] [Abstract][Full Text] [Related]
15. Open pelvic lymph node dissection for prostate cancer: a reassessment. Campbell SC; Klein EA; Levin HS; Piedmonte MR Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933 [TBL] [Abstract][Full Text] [Related]
16. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. Heidenreich A; Varga Z; Von Knobloch R J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387 [TBL] [Abstract][Full Text] [Related]
17. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Sands ME; Zagars GK; Pollack A; von Eschenbach AC Urology; 1994 Aug; 44(2):215-20. PubMed ID: 7519381 [TBL] [Abstract][Full Text] [Related]
18. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer]. Peneau M; Villers A; Molinié V; Theis D; Soulié M Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168 [TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. Palapattu GS; Allaf ME; Trock BJ; Epstein JI; Walsh PC J Urol; 2004 Nov; 172(5 Pt 1):1860-4. PubMed ID: 15540739 [TBL] [Abstract][Full Text] [Related]